Showing results (41-50 of 70) with videos related to
Sort By:
Pageof 7
Molecular Pharmacology|May 4, 2016
Structure-Activity Analysis of Biased Agonism at the Human Adenosine A3 ReceptorJo-Anne Baltos, Silvia Paoletta, Anh T N Nguyen, et al.British Journal of Pharmacology|July 7, 2022
Formylpeptide receptor 2: Nomenclature, structure, signalling and translational perspectives: IUPHAR review 35Cheng Xue Qin, Lucy V Norling, Elizabeth A Vecchio, et al.Cell|February 25, 2017
Structure of the Adenosine A1 Receptor Reveals the Basis for Subtype SelectivityAlisa Glukhova, David M Thal, Anh T Nguyen, et al.Proceedings of the National Academy of Sciences of the United States of America|March 13, 2014
Separation of on-target efficacy from adverse effects through rational design of a bitopic adenosine receptor agonistCeline Valant, Lauren T May, Luigi Aurelio, et al.Chembiochem : a European Journal of Chemical Biology|May 22, 2024
Development of Putative Bivalent Dicovalent Ligands for the Adenosine A1 ReceptorChina M Payne, Jo-Anne Baltos, Monica Langiu, et al.British Journal of Pharmacology|April 19, 2023
The role of the adenosine system in epilepsy and its comorbiditiesJo-Anne Baltos, Pablo M Casillas-Espinosa, Ben Rollo, et al.Biochemical Pharmacology|August 14, 2016
The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signallingElizabeth A Vecchio, Chung Hui Chuo, Jo-Anne Baltos, et al.Journal of Medicinal Chemistry|June 22, 2022
Examining the Role of the Linker in Bitopic N6-Substituted Adenosine Derivatives Acting as Biased Adenosine A1 Receptor AgonistsJon Kyle Awalt, Anh T N Nguyen, Tim J Fyfe, et al.Molecular Pharmacology|May 12, 2012
Allosteric modulation of endogenous metabolites as an avenue for drug discoveryDenise Wootten, Emilia E Savage, Celine Valant, et al.Journal of Medicinal Chemistry|June 14, 2021
Development of Covalent, Clickable Probes for Adenosine A1 and A3 ReceptorsPhuc N H Trinh, Daniel J W Chong, Katie Leach, et al.Pageof 7